| P2093 | author name string | T. Ning | |
| | W-G Xu | |
| | B. Dong | |
| | D-L Hou | |
| | H-C Dong | |
| | D. Hang | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | A distinct "side population" of cells with high drug efflux capacity in human tumor cells | Q24564100 |
| | Prospective identification of tumorigenic breast cancer cells | Q24683474 |
| | Identification and expansion of human colon-cancer-initiating cells | Q27860627 |
| | A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 |
| | Identification of human brain tumour initiating cells | Q27860921 |
| | The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors | Q28214940 |
| | CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells | Q28254370 |
| | Identification and expansion of the tumorigenic lung cancer stem cell population | Q28259332 |
| | Identification of pancreatic cancer stem cells | Q28286997 |
| | Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells | Q28302950 |
| | Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 |
| | Characterization of a side population of cancer cells from human gastrointestinal system | Q33225639 |
| | Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas | Q33318981 |
| | Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma | Q33327359 |
| | Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines | Q33357661 |
| | CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma | Q33974370 |
| | CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer | Q36615659 |
| | Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | Q37449181 |
| | The presence of stem cell marker‐expressing cells is not prognostically significant in glioblastomas | Q38477694 |
| | The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer | Q39822680 |
| | Identification and characterization of tumorigenic liver cancer stem/progenitor cells | Q40119609 |
| | Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line | Q40144546 |
| | Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer | Q47969061 |
| | Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study | Q53457814 |
| | Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas | Q53471082 |
| | Stem cell marker CD133 affects clinical outcome in glioma patients | Q53507481 |
| | Expression profiling of CD133+ and CD133- epithelial cells from human prostate | Q54538010 |
| | TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer | Q73833118 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | squamous cell carcinoma | Q681817 |
| | esophageal squamous cell carcinoma | Q108442577 |
| P304 | page(s) | 638-644 | |
| P577 | publication date | 2012-01-11 | |
| P1433 | published in | Diseases of the Esophagus | Q15766071 |
| P1476 | title | Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma | |
| P478 | volume | 25 | |